<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00516906</url>
  </required_header>
  <id_info>
    <org_study_id>05-010691</org_study_id>
    <nct_id>NCT00516906</nct_id>
  </id_info>
  <brief_title>Clinical Performance of a Chlorhexidine Antimicrobial Dressing</brief_title>
  <official_title>Clinical Performance of a Chlorhexidine Antimicrobial Dressing</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>3M</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of Nebraska</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>3M</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Evaluate the clinical performance of a new IV Dressing in Comparison to a standard IV
      Dressing
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Prospective, controlled, randomized, clinical trial comparing the 3Mâ„¢ TegadermTM CHG
      (Chlorhexidine Gluconate) IV Securement Dressing (3M Healthcare, St Paul, MN) to a standard
      transparent dressing.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>October 2007</start_date>
  <completion_date type="Actual">January 2008</completion_date>
  <primary_completion_date type="Actual">December 2007</primary_completion_date>
  <phase>Phase 2/Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Clinician Overall Satisfaction With Catheter Securement</measure>
    <time_frame>Daily up to 7 Days (average 3-7 days of wear)</time_frame>
    <description>Clinician Overall Satisfaction with Catheter Securement Five Point Scale: 1 = Very Good, 5= Very Poor</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Clinician Overall Satisfaction With Dressing</measure>
    <time_frame>Daily up to 7 Days (average 3-7 days of wear)</time_frame>
    <description>Clinician Overall Satisfaction with Dressing Five point scale: 1= Very Good, 5= Very poor</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rating of Skin Condition</measure>
    <time_frame>Daily up to 7 Days (average 3-7 days of wear)</time_frame>
    <description>Ratings of skin condition for erythema on a 0 to 3 scale (0 = None, 1=Mild, 2=Moderate, 3=Severe)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">68</enrollment>
  <condition>Catheterization</condition>
  <arm_group>
    <arm_group_label>Transparent Adhesive Dressing</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Standard of Care Non-Antimicrobial Transparent Adhesive Dressing</description>
  </arm_group>
  <arm_group>
    <arm_group_label>CHG antimicrobial transparent dressing</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Chlorhexidine gluconate antimicrobial transparent adhesive dressing</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Chlorhexidine gluconate</intervention_name>
    <description>2% Chlorhexidine Transparent Dressing applied as needed up to 7 days of wear</description>
    <arm_group_label>CHG antimicrobial transparent dressing</arm_group_label>
    <other_name>3M(TM) Tegaderm(TM) CHG Dressing</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Transparent Adhesive Dressing</intervention_name>
    <description>Standard of Care Non-antimicrobial Transparent Adhesive Dressing applied as needed for up to 7 days of wear</description>
    <arm_group_label>Transparent Adhesive Dressing</arm_group_label>
    <other_name>TAD, Polyurethane Dressing, Transparent Membrane Dressing</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Males or Females over 18 years of age

          -  Patients with an existing, or newly inserted, central venous catheter

          -  Patients who require the catheter for at least 3 days

        Exclusion Criteria:

          -  Sensitivity to chlorhexidine
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mark E Rupp, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Nebraska Medical Center</affiliation>
  </overall_official>
  <verification_date>July 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 14, 2007</study_first_submitted>
  <study_first_submitted_qc>August 14, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 16, 2007</study_first_posted>
  <results_first_submitted>March 3, 2010</results_first_submitted>
  <results_first_submitted_qc>January 20, 2012</results_first_submitted_qc>
  <results_first_posted type="Estimate">February 23, 2012</results_first_posted>
  <last_update_submitted>July 25, 2012</last_update_submitted>
  <last_update_submitted_qc>July 25, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 1, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Chlorhexidine</mesh_term>
    <mesh_term>Chlorhexidine gluconate</mesh_term>
    <mesh_term>Anti-Infective Agents</mesh_term>
    <mesh_term>Anti-Bacterial Agents</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>The study population included adult males and female patients with an existing, or newly inserted, catheter that was to remain in place for at least 3 days, who were willing to participate in the study, and who would provide informed consent and sign a consent form. First patient enrolled 10 October 2007. Last patient enrolled 20 December 2007</recruitment_details>
      <pre_assignment_details>No Wash out. No run-in</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Placebo Comparator: A</title>
          <description>Standard of Care Transparent Adhesive Dressing</description>
        </group>
        <group group_id="P2">
          <title>CHG Antimicrobial Transparent Dressing</title>
          <description>Chlorhexidine gluconate antimicrobial transparent adhesive dressing</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="36"/>
                <participants group_id="P2" count="32">33 patients were randomized but one patient was discharged prior to treatment.</participants>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="30">Thirty patients were required to complete. Patients not completing were replaced.</participants>
                <participants group_id="P2" count="30">Thirty patients were required to complete. Patients not completing were replaced.</participants>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="6"/>
                <participants group_id="P2" count="2"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Final Dressing Removal Data not captured</title>
              <participants_list>
                <participants group_id="P1" count="6"/>
                <participants group_id="P2" count="2"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Placebo Comparator: A</title>
          <description>Standard of Care Transparent Adhesive Dressing</description>
        </group>
        <group group_id="B2">
          <title>CHG Antimicrobial Transparent Dressing</title>
          <description>Chlorhexidine gluconate antimicrobial transparent adhesive dressing</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="36"/>
            <count group_id="B2" value="32"/>
            <count group_id="B3" value="68"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>&lt;=18 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Between 18 and 65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="24"/>
                    <measurement group_id="B2" value="21"/>
                    <measurement group_id="B3" value="45"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>&gt;=65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="12"/>
                    <measurement group_id="B2" value="11"/>
                    <measurement group_id="B3" value="23"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="58.7" spread="15.1"/>
                    <measurement group_id="B2" value="53.4" spread="18.5"/>
                    <measurement group_id="B3" value="56.0" spread="17.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="20"/>
                    <measurement group_id="B2" value="20"/>
                    <measurement group_id="B3" value="40"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="16"/>
                    <measurement group_id="B2" value="12"/>
                    <measurement group_id="B3" value="28"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="36"/>
                    <measurement group_id="B2" value="32"/>
                    <measurement group_id="B3" value="68"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Clinician Overall Satisfaction With Catheter Securement</title>
        <description>Clinician Overall Satisfaction with Catheter Securement Five Point Scale: 1 = Very Good, 5= Very Poor</description>
        <time_frame>Daily up to 7 Days (average 3-7 days of wear)</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Placebo Comparator: A</title>
            <description>Standard of Care Transparent Adhesive Dressing</description>
          </group>
          <group group_id="O2">
            <title>CHG Antimicrobial Transparent Dressing</title>
            <description>Chlorhexidine gluconate antimicrobial transparent adhesive dressing</description>
          </group>
        </group_list>
        <measure>
          <title>Clinician Overall Satisfaction With Catheter Securement</title>
          <description>Clinician Overall Satisfaction with Catheter Securement Five Point Scale: 1 = Very Good, 5= Very Poor</description>
          <units>Units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="30"/>
                <count group_id="O2" value="30"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.27" spread="0.78"/>
                    <measurement group_id="O2" value="1.63" spread="1.63"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Clinician Overall Satisfaction With Dressing</title>
        <description>Clinician Overall Satisfaction with Dressing Five point scale: 1= Very Good, 5= Very poor</description>
        <time_frame>Daily up to 7 Days (average 3-7 days of wear)</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Placebo Comparator: A</title>
            <description>Standard of Care Transparent Adhesive Dressing</description>
          </group>
          <group group_id="O2">
            <title>CHG Antimicrobial Transparent Dressing</title>
            <description>Chlorhexidine gluconate antimicrobial transparent adhesive dressing</description>
          </group>
        </group_list>
        <measure>
          <title>Clinician Overall Satisfaction With Dressing</title>
          <description>Clinician Overall Satisfaction with Dressing Five point scale: 1= Very Good, 5= Very poor</description>
          <units>Units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="30"/>
                <count group_id="O2" value="30"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.20" spread="0.81"/>
                    <measurement group_id="O2" value="1.63" spread="0.61"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Rating of Skin Condition</title>
        <description>Ratings of skin condition for erythema on a 0 to 3 scale (0 = None, 1=Mild, 2=Moderate, 3=Severe)</description>
        <time_frame>Daily up to 7 Days (average 3-7 days of wear)</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Placebo Comparator: A</title>
            <description>Standard of Care Transparent Adhesive Dressing</description>
          </group>
          <group group_id="O2">
            <title>CHG Antimicrobial Transparent Dressing</title>
            <description>Chlorhexidine gluconate antimicrobial transparent adhesive dressing</description>
          </group>
        </group_list>
        <measure>
          <title>Rating of Skin Condition</title>
          <description>Ratings of skin condition for erythema on a 0 to 3 scale (0 = None, 1=Mild, 2=Moderate, 3=Severe)</description>
          <units>Units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="30"/>
                <count group_id="O2" value="30"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.1" spread="0.29"/>
                    <measurement group_id="O2" value="0.2" spread="0.33"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>The study ran 3 months (10 October 2008- 20 December 2008) The maximum length of exposure of each patient to the dressings was 7.1 days.</time_frame>
      <desc>The insertion site was evaluated each day by study personnel and patients were asked about their well being</desc>
      <group_list>
        <group group_id="E1">
          <title>Placebo Comparator: A</title>
          <description>Standard of Care Transparent Adhesive Dressing</description>
        </group>
        <group group_id="E2">
          <title>CHG Antimicrobial Transparent Dressing</title>
          <description>Chlorhexidine gluconate antimicrobial transparent adhesive dressing</description>
        </group>
      </group_list>
      <serious_events>
        <default_vocab>Other: AE table</default_vocab>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="30"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="30"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Neoplasms benign, malignant and unspecified (incl cysts and polyps)</title>
            <event_list>
              <event>
                <sub_title>Death due to underlying Disease</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="30"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="30"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <default_vocab>Other: AE table</default_vocab>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="30"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="30"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Elevated Temperature</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="30"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="30"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Elevated WBC, No fever, culture negative</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="30"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="30"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Psychiatric disorders</title>
            <event_list>
              <event>
                <sub_title>Intermittent confusion existing prior to start</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="30"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>This trial evaluated the dressing for it's securement and ease of use adaption into healthcare practices compared to a standard transparent dressing. The sample size was too small to evaluate any effect on Catheter Related-Bloodstream Infection.</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>J M Heilman</name_or_title>
      <organization>3M</organization>
      <phone>651-733-9897</phone>
      <email>jmheilman@mmm.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

